Masahiko Takahashi
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Targeting Ubiquitinated Protein Aggregates in Neurodegenerative Diseases: current Status and Future Directions.
Journal: Molecular and cellular biology
Published: August 04, 2026
Dual Regulatory Roles of USP10 in Tau Pathology and Neuronal Fate During Alzheimer's Disease Progression.
Journal: Molecular and cellular biology
Published: December 09, 2025
USP10 inhibits the degradation of α-synuclein, a pathogenic factor associated with Parkinson's disease, by inhibiting chaperone-mediated autophagy.
Journal: The Journal of biological chemistry
Published: November 16, 2024
TDP-43 mutants with different aggregation properties exhibit distinct toxicity, axonal transport, and secretion for disease progression in a mouse ALS/FTLD model.
Journal: Neurobiology of disease
Published: October 25, 2024
USP10 Inhibits Aberrant Cytoplasmic Aggregation of TDP-43 by Promoting Stress Granule Clearance.
Journal: Molecular and cellular biology
Published: January 10, 2022
USP10 inhibits the dopamine-induced reactive oxygen species-dependent apoptosis of neuronal cells by stimulating the antioxidant Nrf2 activity.
Journal: The Journal of biological chemistry
Published: May 12, 2021
Myeloid-associated differentiation marker is an essential host factor for human parechovirus PeV-A3 entry.
Journal: Nature communications
Published: April 11, 2021
G3BP1 inhibits ubiquitinated protein aggregations induced by p62 and USP10.
Journal: Scientific reports
Published: February 19, 2019
USP10 is a critical factor for Tau-positive stress granule formation in neuronal cells.
Journal: Scientific reports
Published: December 31, 2018
Last Updated: 09/26/2026